NCT05429749

Intravenous Iron Supplement to Prevent Postoperative Delirium After Hip Fracture Surgery

• Status: Unknown
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 264 (estimated)
• Sponsor: Seoul National University Bundang Hospital · Academic / Other
• Sex: All
• Age: 65 Years
• Healthy volunteers: Not accepted

Summary

This is a clinical trial to evaluate the effect of intravenous iron supplement with Ferinject (Ferric Carboxymaltose) in preventing postoperative delirium after hip fracture surgery.

Detailed description

We hypothesized that IV iron supplement will (1) decrease postoperative delirium in hip fracture patients and (2) decrease the amount of transfusion and transfusion-related complications.

Conditions

• Hip Fractures

Interventions

Type	Name	Description
DRUG	Ferinject	Intravenous ferinject 1000mg is administered between the admission day and the surgery day.
DRUG	Normal saline	Normal saline 250ml is administered between the admission day and the surgery day.

Timeline

• Start date: 2020-07-30
• Primary completion: 2023-12-31
• Completion: 2024-12-31
• First posted: 2022-06-23
• Last updated: 2022-06-23

Locations

1 site across 1 country: South Korea